ARCHIVES

FDA Approves Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 33 | September 14, 2007

Download PDF Visit The Full Archive

Related Articles

DCPC Developing Hispanic Cancer Control Intervention Program Concept

August 12, 1988

SWOG Wins Funding For H. Pylori Trial.

November 21, 2008

Millers, Jensen, Bereblum Win $100,000 GM awards

June 6, 1980

Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions

November 4, 1983

GAO Report Finds Increase in Self-Referred Pathology Services

August 9, 2013

CPRIT Likely to Get Funding For Two Years; DePinho Announces Austerity Measures

May 17, 2013